Spaventa Andrew

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$49,611.65
Insider Sells Quantity
3
Insider Sells Sum
$21,464.57

Insider Activity of Spaventa Andrew

According to the SEC Form 4 filings, Spaventa Andrew, being in a position of

  1. Chief Executive Officer at Singular Genomics Systems, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1050 shares for $21,465,
    over all time since 2023-11-16, has bought 118468 shares for $49,612, and sold 1050 shares for $21,465.

The largest purchase of all time was on 2023-11-17 and amounted to 75000 shares of Singular Genomics Systems, Inc. for $31,755.

The largest sale of all time was on 2024-11-12 and amounted to 695 shares of Singular Genomics Systems, Inc. for $15,669.

Biography of Spaventa Andrew

No biography is available at this moment.

2024-12-16SaleSingular Genomics Systems, Inc.
OMIC
Chief Executive Officer
180
0.0072%
$20.16$3,629-2.19%
2024-11-12SaleSingular Genomics Systems, Inc.
OMIC
Chief Executive Officer
695
0.0273%
$22.55$15,669-7.23%
2024-09-15SaleSingular Genomics Systems, Inc.
OMIC
Chief Executive Officer
175
0.007%
$12.38$2,167+13.08%
2023-11-17PurchaseSingular Genomics Systems, Inc.
OMIC
Chief Executive Officer
75,000
0.1012%
$0.42$31,755-3.96%
2023-11-16PurchaseSingular Genomics Systems, Inc.
OMIC
Chief Executive Officer
43,468
0.0567%
$0.41$17,857-1.18%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.